{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T01:13:02Z","timestamp":1778721182828,"version":"3.51.4"},"reference-count":38,"publisher":"Impact Journals, LLC","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,7,11]]},"DOI":"10.18632\/oncotarget.16787","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T10:04:54Z","timestamp":1491213894000},"page":"45286-45297","source":"Crossref","is-referenced-by-count":12,"title":["TIAM1 variants improve clinical outcome in neuroblastoma"],"prefix":"10.18632","volume":"8","author":[{"given":"Elena","family":"Sanmart\u00edn","sequence":"first","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yania","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Val\u00e8ncia, Spain"},{"name":"Precision Oncology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Forn\u00e9s-Ferrer","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Zugaza","sequence":"additional","affiliation":[{"name":"Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, Spain"},{"name":"Achucarro Basque Center for Neuroscience, Bizkaia Science and Technology Park, Zamudio, Spain"},{"name":"IKERBASQUE, Basque Foundation for Science, Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adela","family":"Ca\u00f1ete","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Val\u00e8ncia, Spain"},{"name":"Precision Oncology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Castel","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Hospital Universitario y Polit\u00e9cnico La Fe, Val\u00e8ncia, Spain"},{"name":"Precision Oncology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime Font","family":"de Mora","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"},{"name":"Precision Oncology Unit, Instituto de Investigaci\u00f3n Sanitaria La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1074\/jbc.M206733200","article-title":"Guanine nucleotide exchange factor, Tiam1, directly binds to c-Myc and interferes with c-Myc-mediated apoptosis in rat-1 fibroblasts","volume":"278","author":"Sugimura","year":"2003","journal-title":"J Biol Chem"},{"key":"2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1091\/mbc.E15-09-0670","article-title":"PAR3-aPKC regulates Tiam1 by modulating suppressive internal interactions","volume":"27","author":"Kaibuchi","year":"2016","journal-title":"Mol Biol Cell"},{"key":"3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1083\/jcb.201202041","article-title":"Tiam1 interaction with the PAR complex promotes talin-mediated Rac1 activation during polarized cell migration","volume":"199","author":"Ginsberg","year":"2012","journal-title":"J Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/ncb833","article-title":"Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism","volume":"4","author":"Der","year":"2002","journal-title":"Nat Cell Biol"},{"key":"5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nature00848","article-title":"Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours","volume":"417","author":"Collard","year":"2002","journal-title":"Nature"},{"key":"6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.molcel.2009.02.012","article-title":"SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1","volume":"33","author":"Malliri","year":"2009","journal-title":"Mol Cell"},{"key":"7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/375338a0","article-title":"A role for Rac in Tiam1-induced membrane ruffling and invasion","volume":"375","author":"Collard","year":"1995","journal-title":"Nature"},{"key":"8","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nsb719","article-title":"Molecular basis for Rac1 recognition by guanine nucleotide exchange factors","volume":"8","author":"Der","year":"2001","journal-title":"Nat Struct Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/35047014","article-title":"Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1","volume":"408","author":"Sondek","year":"2000","journal-title":"Nature"},{"key":"10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1083\/jcb.137.2.387","article-title":"Regulated membrane localization of Tiam1, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and C-Jun NH2-terminal kinase activation","volume":"137","author":"Collard","year":"1997","journal-title":"J Cell Biol"},{"key":"11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ncb1227","article-title":"PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF\/Tiam1","volume":"7","author":"Kaibuchi","year":"2005","journal-title":"Nat Cell Biol"},{"key":"12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1083\/jcb.139.3.797","article-title":"The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho","volume":"139","author":"Collard","year":"1997","journal-title":"J Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.emboj.7600128","article-title":"Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2","volume":"23","author":"Sugimura","year":"2004","journal-title":"EMBO J"},{"key":"14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nature10910","article-title":"Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes","volume":"483","author":"Lakeman","year":"2012","journal-title":"Nature"},{"key":"15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3349","article-title":"Mutational dynamics between primary and relapse neuroblastomas","volume":"47","author":"Heukamp","year":"2015","journal-title":"Nat Genet"},{"key":"16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2007.14.5839","article-title":"Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience","volume":"27","author":"Michon","year":"2009","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nature07399","article-title":"Oncogenic mutations of ALK kinase in neuroblastoma","volume":"455","author":"Mano","year":"2008","journal-title":"Nature"},{"key":"18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature07397","article-title":"Activating mutations in ALK provide a therapeutic target in neuroblastoma","volume":"455","author":"Gregor","year":"2008","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature07398","article-title":"Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma","volume":"455","author":"Michon","year":"2008","journal-title":"Nature"},{"key":"20","doi-asserted-by":"publisher","first-page":"21840","DOI":"10.18632\/oncotarget.8187","article-title":"Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression","volume":"7","author":"de Torres","year":"2016","journal-title":"Oncotarget"},{"key":"21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2529","article-title":"The genetic landscape of high-risk neuroblastoma","volume":"45","author":"Lichenstein","year":"2013","journal-title":"Nat Genet"},{"key":"22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cell.2010.06.004","article-title":"NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome","volume":"142","author":"Versteeg","year":"2010","journal-title":"Cell"},{"key":"23","doi-asserted-by":"publisher","first-page":"18558","DOI":"10.18632\/oncotarget.4061","article-title":"Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism","volume":"6","author":"Molenaar","year":"2015","journal-title":"Oncotarget"},{"key":"24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.2493","article-title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma","volume":"45","author":"Velculescu","year":"2013","journal-title":"Nat Genet"},{"key":"25","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2350\/15-01-1597-CR.1","article-title":"Identification of Unique, Heterozygous Germline Mutation, STK11 (p.F354L), in a Child with an Encapsulated Follicular Variant of Papillary Thyroid Carcinoma within Six Months of Completing Treatment for Neuroblastoma","volume":"18","author":"Witchel","year":"2015","journal-title":"Pediatr Dev Pathol"},{"key":"26","first-page":"8","article-title":"Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line","volume":"61","author":"Lunec","year":"2001","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/mcpr.1998.0181","article-title":"Absence of MEN2A- or 2B-type RET mutations in primary neuroblastoma tumour tissue","volume":"12","author":"Marshall","year":"1998","journal-title":"Mol Cell Probes"},{"key":"28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cellsig.2013.11.034","article-title":"The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling","volume":"26","author":"Huynh-Do","year":"2014","journal-title":"Cell Signal"},{"key":"29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.molcel.2014.12.040","article-title":"CUL3-KBTBD6\/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling","volume":"57","author":"Behrends","year":"2015","journal-title":"Mol Cell"},{"key":"30","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1158\/0008-5472.CAN-07-6433","article-title":"Phosphoinositide 3-kinase\/AKT signaling can promote AIB1 stability independently of GSK3 phosphorylation","volume":"68","author":"Font de Mora","year":"2008","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"e76761","DOI":"10.1371\/journal.pone.0076761","article-title":"Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor","volume":"8","author":"Font de Mora","year":"2013","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00428-006-0253-y","article-title":"Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry","volume":"449","author":"Llombart-Bosch","year":"2006","journal-title":"Virchows Arch"},{"key":"33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The International Neuroblastoma Pathology Classification (the Shimada system)","volume":"86","author":"Castleberry","year":"1999","journal-title":"Cancer"},{"key":"34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Garaventa","year":"2009","journal-title":"J Clin Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1200\/JCO.2003.03.025","article-title":"Quality assessment of genetic markers used for therapy stratification","volume":"21","author":"Hattinger","year":"2003","journal-title":"J Clin Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-4608(02)00677-5","article-title":"MYCN gain and MYCN amplification in a stage 4S neuroblastoma","volume":"140","author":"Llombart-Bosch","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Mesirov","year":"2011","journal-title":"Nat Biotechnol"},{"key":"38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Committee","year":"2015","journal-title":"Genet Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T16:13:40Z","timestamp":1589127220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":38,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,7,11]]}},"alternative-id":["16787","28423360"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16787","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727531221.793531239","asserted-by":"object"}]},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}